Additional file 5: of A pharmacogenetic signature of high response to Copaxone in late-phase clinical-trial cohorts of multiple sclerosis
Colin Ross
Fadi Towfic
Jyoti Shankar
Daphna Laifenfeld
Mathis Thoma
Matthew Davis
Brian Weiner
Rebecca Kusko
Ben Zeskind
Volker Knappertz
Iris Grossman
Michael Hayden
10.6084/m9.figshare.c.3792238_D8.v1
https://springernature.figshare.com/articles/journal_contribution/Additional_file_5_of_A_pharmacogenetic_signature_of_high_response_to_Copaxone_in_late-phase_clinical-trial_cohorts_of_multiple_sclerosis/5057395
The eleven-SNP model coefficients, odds ratios with 95% Bayesian confidence intervals and posterior inclusion probabilities. (DOCX 15 kb)
2017-05-31 05:00:00
Pharmacogenetics
Copaxone
Glatiramer acetate
Treatment-response
Inter-individual variability
Multiple sclerosis
Multi-SNP signature
Multivariable Bayesian modeling